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Summary
The gluten-free diet, the only treatment in coeliac disease, can be nutritionally unbal-
anced and deficient in several nutrients. Gluten-free products contain much lower levels
of B vitamins, especially lower folate concentrations than their gluten-containing counter-
parts. Folate intake is considered as a major dietary determinant of plasma homocysteine
concentration in healthy population. Elevated homocysteine is an independent risk factor
for cardiovascular disease and has been associated with osteoporotic fractures, which are
an increased risk factor in coeliac disease. The aim of this study is to determine dietary fo-
late intake and plasma homocysteine concentration as metabolic markers of suboptimal in-
take of folate and B12 in Croatian coeliac patients living on a gluten-free diet. Subjects were
52 coeliac patients (83 % female, age 35±13) adhering to a gluten-free diet. Blood samples
were analyzed for plasma homocysteine, serum and red blood cell folate and serum B12.
Quantitative food frequency questionnaire was used to measure dietary folate intake. Mean
dietary folate intake was 206 mg of dietary folate equivalents (DFE), which was far below
the national recommendation of 400 mg of DFE (or 200 mg of folic acid). Mean homocysteine
was (9±2) mmol/L (range from 5.42 to 13.90 mmol/L), while elevated homocysteine con-
centrations (>10 mmol/L) were found in 34 % of subjects. In conclusion, coeliac patients
adhering to gluten-free diet included in this study showed low folate intake and subopti-
mal folate and vitamin B12 status, possibly due to low folate content in gluten-free prod-
ucts. Therefore, folate fortification or enrichment of gluten-free products could be benefi-
cial for coeliac patients and it would be of great interest for the food industry.
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Introduction
Coeliac disease (CD) is a chronic inflammatory multi-
systemic disorder that occurs as a result of an immune
response to ingested gluten in genetically predisposed
individuals. Gluten is a protein found in wheat, rye and
barley. Therefore, CD is treated by excluding all dietary
sources of gluten. Adherence to the gluten-free diet is
necessary to prevent malabsorption and it results in symp-
tomatic, serologic and histological remission in the major-
ity of patients (1). The gluten-free diet is based on gluten-
-free products, which are made from gluten-free flour.
Several types of gluten-free flour are nowadays present
on Croatian market; however, they are composed of dif-
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ferent types of starch. Some of them consist of wheat
starch where gluten has been removed, or of naturally
gluten-free starch such as corn or potato starch. There-
fore, the nutritive quality of gluten-free products is im-
portant. Previous studies suggest that gluten-free diet could
be nutritionally unbalanced and deficient in several nu-
trients (2–4). Gluten-free products contain much lower
folate concentrations than their gluten-containing counter-
parts (5,6), therefore such diet can cause vitamin defi-
ciency. B vitamins, especially folate and cobalamin (B12),
are major determinants of plasma homocysteine (Hcy)
concentration (7). Epidemiological evidence suggests a re-
lationship between elevated total plasma Hcy concentra-
tion and a risk of cardiovascular diseases (8–11), increased
risk of neurodegenerative conditions such as stroke, Alz-
heimer’s and Parkinson’s disease (12,13) as well as oste-
oporotic fractures (14,15). Some of these conditions, such
as osteoporotic fractures, are more prevalent in CD pa-
tients (16).
The aim of this study is to determine dietary folate
intake and plasma homocysteine concentration as a meta-
bolic marker of B vitamins in Croatian coeliac patients
living on a gluten-free diet.
Subjects and Methods
Subjects
The subjects were 52 coeliac patients (83 % female,
age range from 18 to 69). Inclusion criteria were biopsy-
-proven CD, adherence to gluten-free diet and age (³18
years old), while exclusion criterion was the use of drugs
known to interfere with folate metabolism. Patients were
recruited through the Croatian Society for Coeliac Dise-
ase. All participants signed an informed consent form.
The study was approved by the Ethics Committee of the
Institute for Medical Research and Occupational Health
in Zagreb, Croatia.
Methods
Fasting venous blood samples were drawn from sub-
jects to determine Hcy, serum cobalamin, serum folate
and red blood cell (RBC) folate concentration. Blood
samples were collected in tubes containing 7.5 % tripo-
tassium EDTA (BD Vacutainer Systems, Plymouth, UK)
and centrifuged at 2000 rpm for 5 min. Two aliquots of
serum per subject were stored at –20 °C until analysis.
Plasma Hcy concentration, which included both the bound
and unbound fractions of Hcy, was determined with the
fluorescence polarization immunoassay. Mildly elevated
Hcy was considered as >10 mmol/L. Serum B12 concentra-
tion was measured by radioimmunoassay; normal value
range was between 208.0 and 963.5 pg/mL. Folate con-
centration in RBC and serum was measured using an
ion capture assay; normal value range being between 572–
1843 and 16–35 nmol/L, respectively. All parameters were
measured on Abbott Axsym System according to the
manufacturer’s instructions (Abbott Axsym System, Ab-
bott Park, IL, USA) at the Children’s Hospital Zagreb.
Intra-assay coefficient of variation for Hcy, vitamin B12
and folate was 3.1, 3.3 and 3.5 %, respectively.
Dietary intake of folate was assessed by using vali-
dated 39-item food frequency questionnaire (FFQ) as de-
scribed elsewhere (17). FFQ was slightly modified by re-
placing gluten products such as bread, pasta and break-
fast cereals with gluten-free products. The questionnaire
was mailed to the subjects and once completed was re-
turned. Subsequently, blood samples were taken. Folate
intake was calculated as dietary folate equivalents (DFE)
by using food composition tables (18), while for gluten-
-free products, not included in the food composition
tables, folate content was taken from the nutrition in-
formation on the product labels or from manufacturers.
Folate supplement use was recorded separately in a
questionnaire that included brand name, composition,
and amount taken for each supplement. Average daily
supplement intake of folate was computed from the
questionnaire and was added to the folate intake from
food to provide total daily folate intake.
Statistical analysis
Data having normal distribution are presented as
mean values±S.D. Differences among mean values were
assessed using Student’s t-test. The distribution of total
daily folate intake was positively skewed; therefore, log-
-transformed and presented as median and 95 % confi-
dence interval. Pearson’s correlation was used to examine
the correlation between folate intake and biochemical pa-
rameters; p<0.05 was considered significant. Multiple re-
gression analysis was used to examine the influence of
individual factors on Hcy concentration. All statistical anal-
yses were performed with STATISTICA software v. 8 (19).
Results and Discussion
Characteristics of coeliac patients are presented in
Table 1. Coeliac patients were divided into two groups
according to folate supplement usage. Significant differ-
ence was observed between supplement users and non-
-users only for RBC folate and total daily folate intake
(p<0.05). Therefore, for other observed parameters, coe-
liac patients were treated as one group. Subjects includ-
ed in this research were adhering to gluten-free diet on
average for 9 years (range from 0.25 to 30 years). The
mean total plasma Hcy concentration was (9±2) mmol/L.
All observed biochemical parameters were in the recom-
mended range for supplement users, while for non-users
elevated Hcy (>10 mmol/L) was found in 34 % of the
subjects, low plasma folate in 25 % patients, low red
blood folate in 25 % and low serum cobalamin in 14 %
of the subjects. These results are in accordance with the
previous studies among this population. Hallert et al.
(20) reported that despite a 10-year gluten-free diet, 37
% of coeliac patients still have lower folate levels and
higher Hcy levels, indicating a poor vitamin status.
FFQ was used to determine folate intake from food.
No statistical difference was observed between supple-
ment users and non-users regarding folate intake from
food (p>0.05) (Table 1). Mean folate intake from food was
206 mg DFE, which was far below the national recom-
mendation of 400 mg DFE (or 200 mg of folic acid), but
higher than in coeliac patients reported by Hallert et al.
(20) and Grehn et al. (2). Green leafy and leguminous
vegetables supplied 56 % of dietary folate intake, while
grain products contributed less than 10 % of dietary in-
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take. According to Grehn et al. (2) relative contribution
of folate was lower in gluten-free bread vs. gluten-con-
taining bread, despite the fact that the intake of bread
was similar among coeliac patients and healthy controls
in Sweden. It should be noted that in Sweden neither
gluten-free nor gluten products are folate-enriched.
Folate supplements which were used by 15 % of sub-
jects (N=8) were added to folate intake from food to pro-
vide total daily folate intake. As expected, differences be-
tween total daily folate intake between supplement users
and non-users were observed (p<0.05). Patients used fo-
late supplement in dosages of 100 to 680 mg DFE, while
two patients used extra high dosage of 8500 mg DFE.
Pearson’s correlation was done to examine the rela-
tionship between total daily folate intake and biochem-
ical parameters that reflect Hcy concentration, namely
serum folate and RBC folate. For all patients positive cor-
relation was found between total daily folate intake and
folate status (serum and RBC folate), while correlation
with Hcy was negative but it did not reach statistical
significance (Table 2). Positive correlation was also found
between total folate intake and serum folate among sup-
plement users, which can be explained by the fact that
the most recent intake reflects on serum folate levels,
which was considerably higher in supplement users (Table
1). Hallert et al. (21) showed that vitamin B supplements
normalized Hcy and improved subjective health status
of coeliac patients.
Furthermore, correlation was made to examine the
association between Hcy, biochemical parameters and the
duration of gluten-free diet (Fig. 1). Statistically signifi-
cant correlations were found between the concentration
of Hcy and both folate fractions (in serum and in RBC)
and with B12 (p<0.05) for all patients. These correlations
were also observed for non-users of supplements (not
shown). We assumed that the duration of gluten-free diet
could also influence Hcy concentration, since it was found
that the exclusion of gluten from the diet of CD patients
can increase folate status and thus normalize Hcy levels
(22). However, no correlations were found between Hcy
concentrations and the number of years the participants
adhered to gluten-free diet (p=0.788) (Fig. 1).
To further define the role of all observed biochemi-
cal and dietary parameters on Hcy concentration, a mul-
tiple regression analysis was performed where Hcy was
dependent variable and age, duration of gluten-free diet
(years), serum folate, RBC folate, serum B12 and total die-
tary folate intake were the independent variables. The
results show that 31.3 % of the variation in the total plas-
ma Hcy concentration could be explained by RBC folate
and age (p<0.0001). While serum folate reflects the most
recent intake, RBC folate reflects the long-term intake be-
cause folate accumulates during erythropoiesis and ap-
pears to be retained through the life span of the cell (23).
It is well established that Hcy concentration increases with
age (24,25).
513M. BITUH et al.: Lack of Folate and B12 in Gluten-Free Products, Food Technol. Biotechnol. 49 (4) 511–516 (2011)











Age/year 36±3 38±12 35±13 0.370
GF diet/year 9±8 5±4 9±1 0.129
c(Hcy)/(mmol/L) 9±2 9±2 9±2 0.534
c(F(S))/(nmol/L) 22±8 28±10 23±9 0.076
c(F(RBC))/(nmol/L) 761±280 1256±292 839±333 <0.001*
g(B12)/(pg/mL) 339±143 349±137 341±141 0.863
Dietary folate/(mg DFE/day) 203±73 224±163 206±91 0.565
Total folate intaked/(mg DFE/day) 197.61 (18.97–225.45) 731.83 (455.66–5785.90) 220.96 (122.68–1041.25) <0.0001*
all values are expressed as mean±S.D.
GF=gluten-free, Hcy=homocysteine, F(S)=serum folate, F(RBC)=red blood cell folate
aincludes 37 females and 7 males, bincludes 6 females and 2 males, cincludes 43 females and 9 males,
dincludes folate intake from food and supplements (positively skewed, therefore presented as median±95 % CI)
*significant (p<0.05)
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Total folate intake (log[DFE (mg/day)]) vs. Hcy –0.245 0.112 –0.636 0.090 –0.267 0.059
Total folate intake (log[DFE (mg/day)]) vs. serum folate 0.206 0.185 0.742 0.035* 0.431 0.002*
Total folate intake (log[DFE (mg/day)]) vs. RBC folate 0.136 0.385 0.669 0.069 0.563 <0.0001*
Hcy=homocysteine, RBC=red blood cell, total folate intake includes folate intake from food and supplements (positively skewed,
therefore log-transformed), DFE=dietary folate equivalents
*significant (p<0.05)
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Fig. 1. Correlation between plasma homocysteine and red blood cell folate, serum folate, serum B12 and years of adherence to glu-
ten-free diet
Hcy=homocysteine, F(RBC)=red blood cell folate, F(S)=serum folate, GF=gluten-free
Previous research had shown that in healthy subjects
high dietary intake of folate reduces Hcy concentration
in plasma (26). Folate is absorbed in the jejunum, the
proximal segments of which can be inflamed and dam-
aged in active CD. Therefore, elevated Hcy concentra-
tion is frequent in newly diagnosed patients and vita-
min deficiencies caused by malabsorption are the most
important determinants of this condition (27,28). How-
ever, as reported before (2,20) and confirmed by this study,
coeliac patients adhering to gluten-free diet for several
years can also develop folate deficiency, possibly due to
low folate content in gluten-free products.
To increase folate intake in all population, especially
among women to prevent the development of neural tube
defects, food fortification is mandatory in some countries
such as the USA, Canada, Australia and Ireland. Folic
acid is usually added to staple food such as flour for
bread making purposes. However, because coeliac pa-
tients can only consume gluten-free flour, it does not
apply to them. Nowadays, CD is well recognized and
prevalence of CD is about 1 % in the general population
(29,30). Therefore, folate fortification or enrichment of
gluten-free products/flour could be beneficial for coeliac
patients and of great interest for food industry. Our stu-
dy has several limitations, primarily the small sample
size and single centre. Unfortunately, these limitations
were the result of specific inclusion criteria such as ad-
herence to gluten-free diet, age and medical condition of
coeliac patients. Another limitation was the lack of con-
trol group. However, previous research conducted among
young healthy Croatian population showed no clinical
deficit in vitamin B status (31,32). All of these limitations
were taken into account. This research could contribute
to better understanding of the impact of gluten-free diet
on the nutritional status of coeliac patients in Croatia.
Conclusion
Results of this study show that coeliac patients ad-
hering to gluten-free diet included in this study have in-
adequate folate intake and low folate and vitamin B12
status, which was in correlation with mildly elevated Hcy
concentrations. These results may support the need for
dietary counselling for coeliac patients to increase the
intake of folate-rich foods and enriched gluten-free prod-
ucts.
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